Fundamental and intensive care of acute pancreatitis

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 17, Issue 1, 2010, Pages 45-52

  Hirota, Morihisa ^a   Takada, Tadahiro ^b   Kitamura, Nobuya ^c   Ito, Tetsuhide ^d   Hirata, Koichi ^e   Yoshida, Masahiro ^f   Mayumi, Toshihiko ^g   Kataoka, Keisho ^h   Takeda, Kazunori ⁱ   Sekimoto, Miho ^j   Hirota, Masahiko ^k   Kimura, Yasutoshi ^e   Wada, Keita ^b   Amano, Hodaka ^b   Gabata, Toshifumi ^l   Arata, Shinju ^m   Yokoe, Masamichi ⁿ   Kiriyama, Seiki ^o  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c KIMITSU CHUO HOSPITAL   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e SAPPORO MEDICAL UNIVERSITY   (Japan)

^f INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^g NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h Otsu Municipal Hospital   (Japan)

ⁱ SENDAI CITY MEDICAL CENTER   (Japan)

^j KYOTO UNIVERSITY   (Japan)

^k National Hospital Organization   (Japan)

^l KANAZAWA UNIVERSITY   (Japan)

^m YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

ⁿ NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^o OGAKI MUNICIPAL HOSPITAL   (Japan)

more..

Author keywords

Acute pancreatitis; Guidelines; Nutritional support; Prophylactic antibiotics; Protease inhibitor

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; GABEXATE MESILATE; HISTAMINE H2 RECEPTOR ANTAGONIST; MEROPENEM; METRONIDAZOLE; PLACEBO; PROTEINASE INHIBITOR;

ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; ANTIBIOTIC THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR FUNCTION; CLINICAL EFFECTIVENESS; CONTINUOUS HEMODIAFILTRATION; CONTINUOUS INFUSION; DISEASE CONTROL; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; ENTERIC FEEDING; FLUID THERAPY; GASTRIC SUCTION; HUMAN; INFECTION COMPLICATION; INFECTION PREVENTION; INTENSIVE CARE; INTERMETHOD COMPARISON; MORTALITY; MULTIPLE ORGAN FAILURE; NUTRITIONAL SUPPORT; PAIN; PARENTERAL NUTRITION; PATIENT ASSESSMENT; PATIENT CARE; PATIENT MONITORING; RISK REDUCTION; SELECTIVE DIGESTIVE DECONTAMINATION; STOMACH ULCER; URINE VOLUME; ACUTE DISEASE; ANTIBIOTIC PROPHYLAXIS; DIGESTIVE TRACT INTUBATION; EVIDENCE BASED MEDICINE; PAIN ASSESSMENT; PANCREATITIS; PRACTICE GUIDELINE;

ACUTE DISEASE; ANTIBIOTIC PROPHYLAXIS; EVIDENCE-BASED MEDICINE; FLUID THERAPY; HUMANS; INTENSIVE CARE; INTUBATION, GASTROINTESTINAL; NUTRITIONAL SUPPORT; PAIN MEASUREMENT; PANCREATITIS; PRACTICE GUIDELINES AS TOPIC; PROTEASE INHIBITORS;

EID: 77956091318     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-009-0210-7     Document Type: Article

References (88)

1. Sekimoto M, Shikata S, Takada T, et al. Changes in management of acute pancreatitis before and after the publication of evidencebased practice guidelines in 2003. J Hepatobiliary Pancreat Surg 2009. doi:10.1007/s00534-009- 0212-5.
2. Mao EQ, Tang YQ, Fei J, Qin S, Wu J, Li L, et al. Fluid therapy for severe acute pancreatitis in acute response stage. Chin Med J. 2009;122:169-73.
3. Jakobs R, Adamek MU, von Bubnoff AC, Riemann JF. Buprenorphine or procaine for pain relief in acute pancreatitis. A prospective randomized study. Scand J Gastroenterol. 2000;35:1319-23. (Pubitemid 32051648)
4. Kahl S, Zimmermann S, Pross M, Schulz HU, Schmidt U, Malfertheiner P. Procaine hydrochloride fails to relieve pain in patients with acute pancreatitis. Digestion. 2004;69:5-9. (Pubitemid 38332919)
5. Peiró AM, Martínez J, Martínez E, de Madaria E, Llorens P, Horga JF, et al. Efficacy and tolerance of metamizole versus morphine for acute pancreatitis pain. Pancreatology. 2008;8:25-9. (Pubitemid 351587248)
6. Levant JA, Secrist DM, Resin H, Sturdevant RA, Guth PH. Nasogastric suction in the treatment of alcoholic pancreatitis. A controlled study. JAMA. 1974;229:51-2.
7. Naeije R, Salingret E, Clumeck N, De Troyer A, Devis G. Is nasogastric suction necessary in acute pancreatitis? Br Med J. 1978;2:659-60. (Pubitemid 9004107)
8. Field BE, Hepner GW, Shabot MM, Schwartz AA, State D, Worthen N, et al. Nasogastric suction in alcoholic pancreatitis. Dig Dis Sci. 1979;24:339-44. (Pubitemid 9183079)
9. Fuller RK, Loveland JP, Frankel MH. An evaluation of the efficacy of nasogastric suction treatment in alcoholic pancreatitis. Am J Gastroenterol. 1981;75:349-53. (Pubitemid 11005288)
10. Loiudice TA, Lang J, Mehta H, Banta L. Treatment of acute alcoholic pancreatitis: The roles of cimetidine and nasogastric suction. Am J Gastroenterol. 1984;79:553-8. (Pubitemid 14091515)
11. Sarr MG, Sanfey H, Cameron JL. Prospective, randomized trial of nasogastric suction in patients with acute pancreatitis. Surgery. 1986;100:500-4. (Pubitemid 16054076)
12. Navarro S, Ros E, Aused R, García Pugés M, Piqué JM, et al. Comparison of fasting, nasogastric suction and cimetidine in the treatment of acute pancreatitis. Digestion. 1984;30:224-30. (Pubitemid 15210433)
13. Goff JS, Feinberg LE, Brugge WR. A randomized trial comparing cimetidine to nasogastric suction in acute pancreatitis. Dig Dis Sci. 1982;27:1085-8. (Pubitemid 13198250)
14. Meshkinpour H, Molinari MD, Gardner L, Berl JE, Hoehler FK. Cimetidine in the treatment of acute alcoholic pancreatitis. A randomized, double-blind study. Gastroenterology. 1979; 77:687-90. (Pubitemid 9249369)
15. Broe PJ, Zinner MJ, Cameron JL. A clinical trial of cimetidine in acute pancreatitis. Surg Gynecol Obstet. 1982;154:13-6. (Pubitemid 12209892)
16. Loiudice TA, Lang J, Mehta H, Banta L. Treatment of acute alcoholic pancreatitis: The role of cimetidine and nasogastric suction. Am J Gastroenterol. 1984;9:553-8. (Pubitemid 14091515)
17. Morimoto T, Noguchi Y, Sakai T, Shimbo T, Fukui T. Acute pancreatitis and the role of histamine-2 receptor antagonists: A meta-analysis of randomized controlled trials of cimetidine. Eur J Gastroenterol Hepatol. 2002;14:679-86. (Pubitemid 34666648)
18. Craig RM, Dordal E, Myles L. The use of ampicillin in acute pancreatitis. Ann Intern Med. 1975;83:831-2.
19. Finch WT, Sawyers JL, Schenker S. A prospective study to determine the efficacy of antibiotics in acute pancreatitis. Ann Surg. 1976;183:667-71.
20. Howes R, Zuidema GD, Cameron JL. Evaluation of prophylactic antibiotics in acute pancreatitis. J Surg Res. 1975;18:197-200.
21. Büchler M, Malfertheiner P, Friess H, Isenmann R, Vanek E, Grimm H, et al. Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology. 1992;103:1902-8.
22. Pederzoli P, Bassi C, Vesentini S, Campedelli A. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet. 1993;176:480-3. (Pubitemid 23138141)
23. Sainio V, Kemppainen E, Puolakkainen P, Taavitsainen M, Kivisaari L, Valtonen V, et al. Early antibiotic treatment in acute necrotising pancreatitis. Lancet. 1995;346:663-7.
24. Delcenserie R, Yzet T, Ducroix JP. Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis. Pancreas. 1996;13:198-201. (Pubitemid 26266232)
25. Schwarz M, Isenmann R, Meyer H, Beger HG. Antibiotic use in necrotizing pancreatitis. Results of a controlled study. Dtsch Med Wochenschr. 1997;122:356-61. (Pubitemid 27165620)
26. Nordback I, Sand J, Saaristo R, Paajanen H. Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis-a single-center randomized study. J Gastrointest Surg. 2001;5:113-8.
27. Rokke O, Harbitz TB, Liljedal J, Pettersen T, Fetvedt T, Heen LØ, et al. Early treatment of severe pancreatitis with imipenem: A prospective randomized clinical trial. Scand J Gastroenterol. 2007;42:771-6. (Pubitemid 46763574)
28. Manes G, Rabitti PG, Menchise A, Riccio E, Balzano A, Uomo G. Prophylaxis with meropenem of septic complications in acute pancreatitis: A randomized, controlled trial versus imipenem. Pancreas. 2003;27:e79-83.
29. Manes G, Uomo I, Menchise A, Rabitti PG, Ferrara EC, Uomo G. Timing of antibiotic prophylaxis in acute pancreatitis: A controlled randomized study with meropenem. Am J Gastroenteol. 2006;101:1348-53. (Pubitemid 43830004)
30. Isenmann R, Runzi M, Kron M, Kahl S, Kraus D, Jung N, et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: A placebo-controlled, double-blind trial. Gastroenterology. 2004;126:997-1004. (Pubitemid 38451171)
31. Dellinger EP, Tellado JM, Soto NE, Ashley SW, Barie PS, Dugernier T, et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: A randomized, double-blind, placebocontrolled study. Ann Surg. 2007;245:674-83. (Pubitemid 46684095)
32. Golub R, Siddiqi F, Pohl D. Role of antibiotics in acute pancreatitis: A meta-analysis. J Gastrointest Surg. 1998;2:496-503. (Pubitemid 128423128)
33. Sharma VK, Howden CW. Prophylactic antibiotic administration reduces sepsis and mortality in acute necrotizing pancreatitis: A meta-analysis. Pancreas. 2001;22:28-31. (Pubitemid 32046211)
34. Villatoro E, Larvin M, Bassi C. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev. 2003;19:CD002941.
35. Villatoro E, Bassi C, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev. 2006;4:CD002941.
36. Bai Y, Gao J, Zou D, Li ZS. Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: Evidence from a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2008; 103:104-10.
37. de Vries AC, Besselink MG, Buskens E, Ridwan BU, Schipper M, van Erpecum KJ, et al. Randomized controlled trials of antibiotic prophylaxis in severe acute pancreatitis: Relationship between methodological quality and outcome. Pancreatology. 2007;7:531-8. (Pubitemid 47587633)
38. Luiten EJ, Hop WC, Lange JF, Bruining HA. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg. 1995;222:57-65.
39. Stoutenbeek CP, van Saene HK, Miranda DR, Zandstra DF. The effect of selective decontamination of the digestive tract on colonization and infection rate in multiple trauma patients. Intensive Care Med. 1984;10:185-92. (Pubitemid 14071556)
40. Grewe M, Tsiotos GG, Luque de-Leon E, Sarr MG. Fungal infection in acute necrotizing pancreatitis. J Am Coll Surg. 1999;188:408-14. (Pubitemid 29162699)
41. Gotinger P, Wamser P, Barlan M, Sautner T, Jakesz R, Fugger R. Candida infection of local necrosis in severe acute pancreatitis is associated with increased mortality. Shock. 2000;14:320-3.
42. Gloor B, Muller CA, Worni M, Stahel PF, Redaelli C, Uhl W, et al. Pancreatic infection in severe pancreatitis. The role of fungus and multiresistant organisms. Arch Surg. 2001;136:592-6. (Pubitemid 32417551)
43. Isenmann R, Schwarz M, Rau B, Trautmann M, Schober W, Med C, et al. Characteristics of infection with candida species in patients with necrotizing pancreatitis. World J Surg. 2002;25:372-6. (Pubitemid 36920418)
44. De Waele JJ, Vogelaers D, Blot S, Colardyn F. Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy. Clin Infect Dis. 2003;37:208-13. (Pubitemid 36930351)
45. Conner S, Alexakis N, Neal T, Raraty M, Ghaneh P, Evans J, et al. Fungal infection but not type of bacterial infection is associated with a high mortality in primary and secondary infected pancreatic necrosis. Dig Surg. 2004;21:297-304. (Pubitemid 39370395)
46. Shrikhande S, Friess H, Issengger C, Martignoni M, Yong H, Gloor B, et al. Fluconazole penetration into the pancreas. Antimicrob Agents Chemother. 2000;44:2569-71. (Pubitemid 30650921)
47. He YM, Lv XS, Ai ZL, Liu ZS, Qian Q, Sun Q, et al. Prevention and therapy of fungal infection in severe acute pancreatitis: A prospective clinical study. World J Gastroenterol. 2003;9:2619-21. (Pubitemid 37461283)
48. Skyring A, Singer A, Tornya P. Treatment of acute pancreatitis with Trasylol: Report of a controlled therapeutic trial. Br Med J. 1965;5462:627-9.
49. Baden H, Jordal K, Lund F, Zachariae F. A double-blind controlled clinical trial of Trasylol. Preliminary results in acute pancreatitis and in prophylaxis against postoperative pancreatitis. Acta Chir Scand Suppl. 1967;378:97-102.
50. Imrie CW, Benjamin IS, Ferguson JC, McKay AJ, Mackenzie I, O'Neill J, et al. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg. 1978;65:337-41. (Pubitemid 8323026)
51. Valderrama R, Perez-Mateo M, Navarro S, Vázquez N, Sanjosé L, Adrián MJ, et al. Multicenter double-blind trial of gabexate mesylate (FOY) in unselected patients with acute pancreatitis. Digestion. 1992;51:65-70.
52. Yang CY, Chang-Chien CS, Liaw YF. Controlled trial of protease inhibitor gabexelate mesilate (FOY) in the treatment of acute pancreatitis. Pancreas. 1987;2:698-700.
53. Buchler M, Malfertheiner P, Uhl W, Schölmerich J, Stöckmann F, Adler G, et al. Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology. 1993; 104:1165-70. (Pubitemid 23090772)
54. Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ, et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini Consensus Conference report. Int J Pancreatol. 1999;25:195-210. (Pubitemid 29379961)
55. Chen HM, Chen JC, Hwang TL, Jan YY, Chen MF. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction. Hepatogastroenterology. 2000;47:1147-50.
56. Andriulli A, Leandro G, Clemente R, Festa V, Caruso N, Annese V, et al. Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther. 1998;12:237-45. (Pubitemid 28160018)
57. Seta T, Noguchi Y, Shimada T, Shikata S, Fukui T. Treatment of acute pancreatitis with protease inhibitors: A meta-analysis. Eur J Gastroenterol Hepatol. 2004;16:1287-93. (Pubitemid 39627527)
58. Freise J, Melzer P, Schmidt FW, Horbach L. Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients. Z Gastroenterol. 1986;24:200-11. (Pubitemid 16120564)
59. Goebell H. Multicenter double-blind study of gabexate mesilate (Foy) given intravenously in low dose in acute pancreatitis. Digestion. 1988;40:73. (abstract).
60. Trapnell JE, Rigby CC, Talbot CH, Duncan EH. A controlled trial of Trasylol in the treatment of acute pancreatitis. Br J Surg. 1974;61:177-82.
61. Bachrach WH, Schild PD. A double-blind study of Trasylol in the treatment of pancreatitis. Ann N Y Acad Sci. 1968;146:580-92.
62. Marik PE, Zaloga GP. Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis. BMJ. 2004;328:1407-12.
63. McClave SA, Greene LM, Snider HL, Makk LJ, Cheadle WG, Owens NA, et al. Comparison of the safety of early enteral vs parenteral nutrition in mild acute pancreatitis. JPEN J Parenter Enteral Nutr. 1997;21:14-20. (Pubitemid 27030051)
64. Windsor AC, Kanwar S, Li AG, Barnes E, Guthrie JA, Spark JI, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut. 1998;42:431-5. (Pubitemid 28197037)
65. Kalfarentzos F, Kehagias J, Mead N, Kokkinis K, Gogos CA. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: Results of a randomized prospective trial. Br J Surg. 1997;84:1665-9. (Pubitemid 27519591)
66. Olah A, Pardavi G, Belagyi T, Nagy A, Issekutz A, Mohamed GE. Early nasojejunal feeding in acute pancreatitis is associated with a lower complication rate. Nutrition. 2002;18:259-62. (Pubitemid 34204138)
67. Abou-Assi S, Craig K, O'Keefe SJ. Hypocaloric jejunal feeding is better than total parenteral nutrition in acute pancreatitis: Results of a randomized comparative study. Am J Gastroenterol. 2002;97:2255-62.
68. Gupta R, Patel K, Calder PC, Yaqoob P, Primrose JN, Johnson CD. A randomised clinical trial to assess the effect of total enteral and parenteral nutritional support on metabolic, inflammatory and oxidative markers in patients with predicted severe acute pancreatitis (APACHE II C 6). Pancreatology. 2003;3: 406-13. (Pubitemid 37409870)
69. Petrov MS, Kukosh MV, Emelyanov NV. A randomized controlled trial of enteral versus parenteral feeding in patients with predicted severe acute pancreatitis shows a significant reduction in mortality and in infected pancreatic complications with total enteral nutrition. Dig Surg. 2006;23(5-6):336-44.
70. Eatock FC, Chong P, Menezes N, Murray L, McKay CJ, Carter CR, et al. A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis. Am J Gastroenterol. 2005;100:432-9. (Pubitemid 40314531)
71. Petrov MS, Correia MI, Windsor JA. Nasogastric tube feeding in predicted severe acute pancreatitis. A systematic review of the literature to determine safety and tolerance. JOP. 2008;9(4):440-8.
72. Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg. 2002;89:1103-7. (Pubitemid 34989215)
73. Fuentes-Orozco C, Cervantes-Guevara G, Muciño-Hernández I, López-Ortega A, Ambriz-González G, Gutiérrez-de-la-Rosa JL, et al. L-Alanyl-L-glutamine-supplemented parenteral nutrition decreases infectious morbidity rate in patients with severe acute pancreatitis. JPEN J Parenter Enteral Nutr. 2008;32(4):403-11. (Pubitemid 351875937)
74. Wang X, Li W, Li N, Li J. Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: A randomized and controlled study. JPEN J Parenter Enteral Nutr. 2008;32(3):236-41. (Pubitemid 351571258)
75. Pearce CB, Sadek SA, Walters AM, Goggin PM, Somers SS, Toh SK, et al. A double-blind, randomised, controlled trial to study the effects of an enteral feed supplemented with glutamine, arginine, and omega-3 fatty acid in predicted acute severe pancreatitis. JOP. 2006;7(4):361-71. (Pubitemid 44083107)
76. Oláh A, Belágyi T, Pótó L, Romics L Jr, Bengmark S. Synbiotic control of inflammation and infection in severe acute pancreatitis: A prospective, randomized, double blind study. Hepatogastroenterology. 2007;54(74):590-4. (Pubitemid 46724735)
77. Petrov MS, Atduev VA, Zagainov VE. Advanced enteral therapy in acute pancreatitis: Is there a room for immunonutrition? A meta-analysis. Int J Surg. 2008;6(2):119-24.
78. Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. Lancet. 2008;371(9613):651-9.
79. Inoue K, Hirota M, Kimura Y, Kuwata K, Ohmuraya M, Ogawa M. Further evidence for endothelin as an important mediator of pancreatic and intestinal ischemia in severe acute pancreatitis. Pancreas. 2003;26:218-23. (Pubitemid 36384151)
80. Takeda K, Mikami Y, Fukuyama S, Egawa S, Sunamura M, Ishibashi T, et al. Pancreatic ischemia associated with vasospasm in the early phase of human acute necrotizing pancreatitis. Pancreas. 2005;30:40-9. (Pubitemid 40070625)
81. Takeda K, Matsuno S, Sunamura M, Kakugawa Y. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis. Am J Surg. 1996;171:394-8. (Pubitemid 26105206)
82. Takeda K, Matsuno S, Ogawa M, Watanabe S, Atomi Y. Continuous regional arterial infusion (CRAI) therapy reduces the mortality rate of acute necrotizing pancreatitis: Result of a cooperative national survey in Japan. J Hepatobiliary Pancreat Surg. 2001;8:216-20. (Pubitemid 33690540)
83. Ino Y, Arita Y, Akashi T, Kimura T, Igarashi H, Oono T, et al. Continuous regional arterial infusion therapy with gabexate mesilate for severe acute pancreatitis. World J Gastroenterol. 2008;14:6382-7.
84. Imaizumi H, Kida M, Nishimaki H, Okuno J, Kataoka Y, Kida Y, et al. Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit. Pancreas. 2004;4:369-73. (Pubitemid 38509739)
85. Anai H, Sakaguchi H, Uchida H, Matsuo N, Tanaka T, Yoshioka T, et al. Continuous arterial infusion therapy for severe acute pancreatitis: Correlation between CT arteriography and therapeutic effect. J Vasc Interv Radiol. 1999;10:1335-42.
86. Hirota M, Inoue K, Kimura Y, Mizumoto T, Kuwata k, Ohmuraya M, et al. Non-occlusive mesenteric ischemia and its associated intestinal gangrene in acute pancreatitis. Pancreatology. 2003;3:316-22. (Pubitemid 36928756)
87. Matsuno S, Ogawa M, Watanabe S, Atomi Y. National survey for the efficacy of blood purification therapy in severe acute pancreatitis in Japan. Annual report of the Research Committee of Intractable Diseases of the Pancreas. 1998. p. 36-41.
88. Oda S, Hirasawa H, Shiga H, Matsuda K, Nakamura M, Watanabe E, et al. Management of intra-abdominal hypertension in patients with severe acute pancreatitis with continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter. Ther Apher. 2005;9:335-61.